RICI HEALTH (01526) spent HKD 9,150 on August 31 to repurchase 11,000 shares.
Ruitai Medical (01526) announced that on August 31, 2026, the company spent HKD 9,150,000 to repurchase 11,000 shares at a repurchase price of HKD 0.8-0.84 per share.
RICI HEALTH (01526) announced that on August 31, 2026, the company will repurchase 11,000 shares at a cost of HK$9,150, with the repurchase price per share ranging from HK$0.80 to HK$0.84.
Related Articles
BRIGHTSTAR TECH (08446) announced its interim results, with a profit attributable to shareholders of HKD 4.237 million, a decrease of 39.65% compared to the same period last year.
CSPC PHARMA (01093): The Phase I clinical trial of SYH2092 injection for weight management in adults with overweight or obesity has officially launched at the first research center in China.
XINKONG INT CAP (00993) announced its interim results, with a net loss attributable to equity holders of approximately HKD 341 million, narrowing by 31.43% year-on-year.
BRIGHTSTAR TECH (08446) announced its interim results, with a profit attributable to shareholders of HKD 4.237 million, a decrease of 39.65% compared to the same period last year.
CSPC PHARMA (01093): The Phase I clinical trial of SYH2092 injection for weight management in adults with overweight or obesity has officially launched at the first research center in China.
XINKONG INT CAP (00993) announced its interim results, with a net loss attributable to equity holders of approximately HKD 341 million, narrowing by 31.43% year-on-year.
RECOMMEND
